Congress Trades in Nucor Corporation (NUE)

6 members of Congress have disclosed trading NUE.

Total trades
12
Purchases
5
Sales
7
Members
6
Est. volume
$303,001
Last traded
Mar 31, 2025
Want the fundamentals on NUE?
See Nucor Corporation's price, P/E, ROE and a free return calculator.
NUE stock analysis →

6 members of Congress have disclosed trading Nucor Corporation (NUE), with 12 transactions in total — 5 purchases and 7 sales worth an estimated $303,001 at range midpoints, leaning toward selling. The most active NUE trader is Virginia Foxx (5 disclosures). The most recent disclosed NUE trade was on Mar 31, 2025. See our full NUE fundamentals page for price, valuation and a return calculator.

Every disclosed NUE trade

DisclosedPoliticianTypeAmountTraded
Apr 3, 2025 Jefferson Shreve R Sale $15,001 - $50,000 Mar 31, 2025 filing ↗
Nov 2, 2022 Virginia Foxx R Sale $50,001 - Nov 2, 2022 filing ↗
Sep 14, 2022 Virginia Foxx R Purchase $50,001 - $100,000 Sep 14, 2022 filing ↗
May 8, 2020 Gilbert Cisneros D Purchase $1,001 - $15,000 Apr 29, 2020 filing ↗
Apr 15, 2020 Gilbert Cisneros D Sale $1,001 - $15,000 Mar 18, 2020 filing ↗
Mar 31, 2020 Daniel Meuser R Sale $1,001 - $15,000 Mar 31, 2020 filing ↗
Sep 10, 2019 Gilbert Cisneros D Purchase $1,001 - $15,000 Aug 14, 2019 filing ↗
Jun 30, 2019 Donna Shalala Sale $1,001 - $15,000 Jun 24, 2019 filing ↗
Nov 15, 2017 Virginia Foxx R Sale $15,001 - $50,000 Nov 15, 2017 filing ↗
Jan 31, 2017 Virginia Foxx R Purchase $1,001 - $15,000 Jan 31, 2017 filing ↗
Dec 15, 2016 Virginia Foxx R Purchase $15,001 - $50,000 Dec 15, 2016 filing ↗
Jan 1, 2016 Thomas MacArthur Sale $15,001 - $50,000 Dec 16, 2015 filing ↗

Most active NUE traders in Congress

Virginia Foxx Virginia Foxx Republican 5 trades Gilbert Cisneros Gilbert Cisneros Democrat 3 trades Jefferson Shreve Jefferson Shreve Republican 1 trade Daniel Meuser Daniel Meuser Republican 1 trade DS Donna Shalala 1 trade TM Thomas MacArthur 1 trade

Source: US House Clerk Periodic Transaction Reports. Amounts are disclosed as ranges; estimates use range midpoints. Data may be delayed or contain filer errors. Not investment advice.